ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives

Zhang, Honglin; Chen, Yiyan; Liu, Qiuyu; Xiao, Wen-Wen; Shao, Li-Dong*; Pan, Zheng-Hong*; Chen, Chuan-Huizi*; Li, Dashan*云南大学; 中国科学院
Bioorganic and Medicinal Chemistry Letters2023-3-1DOI: 10.1016/j.bmcl.2023.129187
8阅读
引用收藏
分享

摘要

Toosendanin (TSN) is a natural anti-cancer compound that is isolated from the traditional Chinese herbal Melia toosendan Sieb et Zucc. However, the research effect of TSN in the treatment of Triple negative breast cancer (TNBC) is still far from ideal. In this work, we investigated TSN and its derivatives in terms of their actions against MDA-MB-231 and HCC1806 TNBC cell lines. The results indicated that TSN and its derivative 11 showed excellent antitumor activity. Preliminary mechanistic studies showed that both compounds TSN and 11 induced S-phase arrest and G2/M phase cell number decrease in HCC1806 cells. Also, TSN and 11 significantly reduced the protein level of the well-known cancer suppressor gene p53, reduced the phosphorylation of AKT and ERK, and also induced the accumulation of phosphorylated p38 and p21.

学科与关键词

关键词
ToosendaninTriple negative breast cancerStructure-activity relationshipsMechanism
相关
加载中…
  • Development of actein derivatives as potent anti-triple negative breast cancer agents
    Zhang, Honglin; Chen, Yiyan; Huang, Songwen; Xiao, Wen-Wen; Qiu, Ming-Hua*; Shao, Li-Dong*; Chen, Chuan-Huizi*; Li, Dashan*Bioorganic and Medicinal Chemistry Letters, 2023, 89: 129307.被引 1
  • Cytotoxic Compounds from Belamcanda chinensis (L.) DC Induced Apoptosis in Triple-Negative Breast Cancer Cells
    Guo, Ya-Ping; Yi, Peng; Shi, Qi-Qi; Yu, Rui-Rui; Wang, Jin-Hui; Li, Chen-Yang*; Wu, Hai-Qiang*MOLECULES, 2023, 28(12): 4715.
  • Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor
    Han, Rui*; Yang, Hongxing; Ling, Changquan; Lu, Lingeng*Cancer Cell International, 2022, 22(1): 368.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic and Medicinal Chemistry Letters
发表日期
2023-03-01
卷期
第 83 卷
页码
129187
DOI
10.1016/j.bmcl.2023.129187
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81960631, 22267024]; Yunnan Fundamental Research Project [202001AS070038]; Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Chinese Medicine [202101AZ070001-039]; Foundation of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization [FPRU2018-3]; Yunnan Talents Support Plan-Young Talents Project; Start-up Fund of Yunnan University of Chinese Medicine [2019YZG03]; Bioactive Ethno-pharmacol Molecules Chemical Conversion and Application Innovation Team of Department of Education of Yunnan Province

作者

  • Z

    Zhang, Honglin (第一作者)

    yunnan univ

  • C

    Chen, Yiyan

    yunnan univ

查看全部 8 位作者收起作者
  • L

    Liu, Qiuyu

    yunnan univ

  • X

    Xiao, Wen-Wen

  • S

    Shao, Li-Dong (通讯)

    yunnan univ

  • P

    Pan, Zheng-Hong (通讯)

    chinese acad sci · guangxi inst bot

  • C

    Chen, Chuan-Huizi (通讯)

    yunnan univ

  • L

    Li, Dashan (通讯)

    yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417